European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Executive Insights

Life Sciences & Pharma

Advanced In Vitro Models: Opportunities and Challenges for US Drug Development

May 7, 2025

Life Sciences & Pharma

Unlocking Growth: Singapore's Role in Advancing Life Sciences and Medtech Innovations

March 10, 2025

Published Articles

Digital

It’s time to go all-in on digital: Four key strategies of successful leaders

November 7, 2024

Biotech and Pharmaceuticals

Supporting an Emerging Biopharma To Build Out AI With Confidence

October 22, 2024

Published Articles

Data & Analytics

Use Data and Analytics to Create Your Strategy, Not Just Drive It: Why Critical Decisions…

July 23, 2024

Executive Insights

Contract/Pharma Services

Key Trends for CDMOs Partnering With Cell Therapy Developers

July 11, 2024